Sign in to continue:

Thursday, March 5th, 2026

Comerica Incorporated 2024 Annual Financial Report: Consolidated Statements, Internal Controls, and Loan Portfolio Analysis





Comerica Incorporated 2024 Financial Audit & Results: Key Highlights for Investors

Comerica Incorporated: 2024 Financial Audit & Results – Key Insights for Investors

Summary of Key Findings

  • Unqualified Audit Opinion: Comerica received an unqualified (“clean”) audit opinion from Ernst & Young LLP on both its financial statements and its internal controls over financial reporting for the year ended December 31, 2024.
  • Net Income Decline: Net income attributable to common shareholders fell to \$671 million in 2024, down from \$854 million in 2023 and \$1,122 million in 2022.
  • Comprehensive Income Drops Sharply: Comprehensive income dropped to \$585 million in 2024 from \$1,575 million in 2023. This reflects both lower net income and other comprehensive losses, mainly due to unrealized losses on investment securities.
  • Earnings Per Share (EPS): Basic EPS was \$5.06 in 2024, down from \$6.47 in 2023 and \$8.56 in 2022. Diluted EPS was \$5.02 in 2024, compared to \$6.44 in 2023 and \$8.47 in 2022.
  • Allowance for Credit Losses (ACL): The critical audit matter highlighted was the methodology and assumptions used in estimating the ACL, which requires significant management judgment due to economic uncertainties and portfolio risk factors.
  • Dividend and Share Repurchase Activity: The company paid \$376 million in common stock dividends and \$23 million in preferred stock dividends in 2024. Comerica repurchased 1.5 million shares at an average price of \$63.50 per share during the year.
  • Accumulated Other Comprehensive Loss: At year-end 2024, Comerica reported a significant accumulated other comprehensive loss of \$3.16 billion, largely due to unrealized losses on its available-for-sale securities portfolio.
  • Strong Capital and Liquidity Management: The company issued \$1 billion of new medium- and long-term debt and redeemed \$500 million during 2024. No new preferred stock was issued.

Detailed Financial Performance

Income Statement Highlights

  • Total Interest Income: \$3.94 billion in 2024 (down from \$4.18 billion in 2023), reflecting lower interest rates and/or loan balances.
  • Total Interest Expense: \$1.75 billion in 2024, up from \$1.66 billion in 2023, driven by higher deposit and debt costs.
  • Net Interest Income: \$2.19 billion in 2024, a significant decline from \$2.51 billion in 2023 and \$2.47 billion in 2022.
  • Noninterest Income: \$1.05 billion, relatively stable compared to prior years.
  • Noninterest Expense: Salaries and benefits remained the largest expense at \$1.35 billion, with other expenses also stable.
  • Provision for Credit Losses: The company continues to maintain a robust allowance for credit losses, with management highlighting the use of updated economic forecasts and qualitative overlays in response to economic uncertainty.

Balance Sheet and Capital Management

  • Investment Securities: Nearly all classified as available-for-sale, with no allowance for credit losses recorded, reflecting the high quality (primarily U.S. government and agency securities).
  • Shareholders’ Equity: Common equity stood at \$7.9 billion at the end of 2024, with preferred equity unchanged at \$400 million.
  • Share Repurchase: 1.5 million shares were repurchased in 2024; no repurchases occurred in 2023.
  • Dividend Policy: The common dividend remained steady at \$2.84 per share in 2024.

Critical Audit Matter: Allowance for Credit Losses

The external auditor, Ernst & Young LLP, identified the allowance for credit losses (ACL) as a critical audit matter due to its complexity and reliance on management judgment. The ACL is influenced by economic forecasts, portfolio credit quality, and qualitative adjustments to account for model, input, and foresight risk.

  • The audit involved extensive evaluation of management’s credit loss models, assumptions, and data inputs, including scenario analysis and benchmarking against peer data.
  • Investors should note that changes in economic outlook or credit quality could materially affect future earnings and capital levels.

Other Potentially Price-Sensitive Items

  • Unrealized Losses on Securities: Comerica’s accumulated other comprehensive loss has grown substantially, primarily due to unrealized losses on investment securities from rising interest rates. The company expects to reclassify \$198 million of these losses to earnings over the next year, which could impact future reported results.
  • LIBOR/BSBY Transition: Comerica completed its transition from LIBOR and Bloomberg Short-Term Bank Yield Index (BSBY) to alternative reference rates. In 2023 and 2024, the de-designation of \$7 billion in swaps resulted in \$130 million of net losses recognized in noninterest income.
  • Regulatory and Accounting Updates: Several new FASB accounting standards are being adopted or evaluated, including those affecting tax credit investments, segment reporting, and income tax disclosures. Investors should monitor future disclosures for further impacts.

Goodwill and Intangible Asset Testing

The company performed its annual goodwill impairment test in Q3 2024 and concluded that no impairment was necessary, as all reporting units’ fair values exceeded their carrying amounts. However, ongoing monitoring is warranted, especially if economic or market conditions deteriorate.

Investor Takeaways

  • Declining Profitability: The significant drop in net income and earnings per share, combined with rising credit and market risk, are material concerns for shareholders and could pressure the stock price.
  • Capital Position Remains Solid: Despite net income decline, capital and liquidity remain strong, with continued dividends and share repurchases.
  • Interest Rate Risk: The large unrealized losses on the securities portfolio could be a drag on future results if rates remain elevated or rise further.
  • Credit Risk: The ACL remains a key area of management and audit focus, reflecting ongoing economic uncertainty and credit portfolio monitoring.

Conclusion

Comerica’s 2024 results reflect the challenges of a higher interest rate environment, increased credit risk, and a tougher operating environment for regional banks. While the company remains well-capitalized and continues to return capital to shareholders, investors should closely watch credit quality trends, the impact of unrealized securities losses, and any changes to dividend or share repurchase policy.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with a financial advisor before making investment decisions. Past performance is not indicative of future results.




View FIFTH THIRD BANCORP Historical chart here



Protolabs Annual Report 2025: Digital Manufacturing, Corporate Responsibility, Risks, and Executive Leadership Overview

Proto Labs 2025 Annual Report – Investor Analysis Proto Labs 2025 Annual Report – Key Highlights and Investor Insights 1. Executive Summary Proto Labs (NYSE: PRLB), a digital manufacturer serving product developers and engineers,...

Geron Corporation 2025 Annual Report: RYTELO Commercialization, Risks, and Business Overview

Company Overview Geron Corporation (Nasdaq: GERN) is now a commercial-stage biopharmaceutical company, focused on changing the treatment landscape for hematologic malignancies and other cancers. The company’s main product, RYTELO™ (imetelstat), has reached commercial launch...

Odyssey Marine Exploration and Capital Latinoamericano Form Joint Venture for Mexican Phosphate Project – 8-K Filing Details and Agreement Highlights

Odyssey Marine Exploration (OMEX) Enters Amended and Restated JV Agreement: Key Details and Investor Impact Odyssey Marine Exploration (OMEX) Announces Amended and Restated Joint Venture Agreement Major Milestone in Mexican Offshore Phosphate Project Progress...

   Ad